Gesamtpublikationsliste
2019
209.
S. Movérare-Skrtic,
K. Nilsson,
P. Henning,
T. Funck-Brentano,
M. Nethander,
F. Rivadeneira,
G. Coletto Nunes,
A. Koskela,
J. Tuukkanen,
J. Tuckermann,
C. Perret,
P. Souza,
U. H. Lerner and
C. Ohlsson,
"Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans",
FASEB J.,
vol. 33,
no. 10,
pp. 11163-11179,
07
2019.
208.
P. Pfänder,
M. Fidan,
U. Burret,
L. Lipinski and
S. Vettorazzi,
"Cdk5 Deletion Enhances the Anti-inflammatory Potential of GC-Mediated GR Activation During Inflammation",
Front. Immunol.,
vol. 10,
no. 10,
pp. 1554,
Jul.
2019.
207.
T. Desgeorges,
G. Caratti,
R. Mounier,
J. Tuckermann and
B. Chazaud,
"Glucocorticoids Shape Macrophage Phenotype for Tissue Repair",
Front Immunol.,
no. 10,
pp. 1591,
07
2019.
206.
L. van Weert,
J. Buurstede,
H. Sips,
S. Vettorazzi,
I. Mol,
J. Hartmann,
S. Prekovic,
W. Zwart,
M. Schmidt,
B. Roozendaal,
J. Tuckermann,
R. Sarabdjitsingh and
O. Meijer,
"Identification of mineralocorticoid receptor target genes in the mouse hippocampus",
J Neuroendocrinol.,
no. 8,
pp. e12735,
Mai
2019.
205.
N. Tangudu,
N. Buth,
P. Strnad,
I. Cirstea and
M. Spasic´,
"Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions",
Pharmaceuticals (Basel),
vol. 7,
no. 12,
pp. 2,
Mai
2019.
204.
C. Glantschnig,
M. Koenen,
M. Gil-Lozano,
M. Karbiener,
I. Pickrahn,
J. Williams-Dautovich,
R. Patel,
C. Cummins,
M. Giroud,
G. Hartleben,
E. Vogl,
M. Blüher,
J. Tuckermann,
H. Uhlenhaut,
S. Herzig and
M. Scheideler,
"A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling",
FASEB J.,
vol. 33,
no. 5,
pp. 5924-5941,
Feb.
2019.
203.
L. Roth,
J. Wakim,
E. Wasserman,
M. Shalev,
E. Arman,
M. Stein,
V. Brumfeld,
C. Sagum,
M. Bedford,
J. Tuckermann and
A. Elson,
"Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo",
Sci Signal,
vol. 8,
no. 12,
pp. 563,
Jan.
2019.
202.
H. H. Conaway,
P. Henning,
A. Lie,
J. Tuckermann and
U. H. Lerner,
"Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D, javax.xml.bind.JAXBElement@ee08377, and parathyroid hormone-induced osteoclastogenesis.",
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
vol. 33,
pp. 14394--14409,
Dez.
2019.
DOI: | 10.1096/fj.201802729RRR |
201.
S. Movérare-Skrtic,
K. H. Nilsson,
P. Henning,
T. Funck-Brentano,
M. Nethander,
F. Rivadeneira,
G. Coletto Nunes,
A. Koskela,
J. Tuukkanen,
J. Tuckermann,
C. Perret,
P. P. C. Souza,
U. H. Lerner and
C. Ohlsson,
"Osteoblast-derived NOTUM reduces cortical bone mass in mice and the , javax.xml.bind.JAXBElement@5166fe8c, locus is associated with bone mineral density in humans.",
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
vol. 33,
pp. 11163--11179,
Okt.
2019.
DOI: | 10.1096/fj.201900707R |
200.
L. Escoter-Torres,
G. Caratti,
A. Mechtidou,
J. Tuckermann,
N. H. Uhlenhaut and
S. Vettorazzi,
"Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor.",
Frontiers in immunology,
vol. 10,
pp. 1859,
2019.
DOI: | 10.3389/fimmu.2019.01859 |
199.
M. Ahmad,
Y. Hachemi,
K. Paxian,
F. Mengele,
M. Koenen and
J. Tuckermann,
"A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology.",
Frontiers in immunology,
vol. 10,
pp. 2460,
2019.
DOI: | 10.3389/fimmu.2019.02460 |
198.
T. Javaheri,
Z. Kazemi,
J. Pencik,
H. T. T. Pham,
M. Kauer,
R. Noorizadeh,
B. Sax,
H. Nivarthi,
M. Schlederer,
B. Maurer,
M. Hofbauer,
D. N. T. Aryee,
M. Wiedner,
E. M. Tomazou,
M. Logan,
C. Hartmann,
J. P. Tuckermann,
L. Kenner,
M. Mikula,
H. Dolznig,
A. Üren,
G. H. Richter,
F. Grebien,
H. Kovar and
R. Moriggl,
"Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.",
Cell death & disease,
vol. 10,
pp. 605,
Aug.
2019.
DOI: | 10.1038/s41419-019-1853-1 |
197.
N. K. Tangudu,
N. Buth,
P. Strnad,
I. C. Cirstea and
M. V. Spasic,
"Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions.",
Pharmaceuticals (Basel, Switzerland),
vol. 12,
Mai
2019.
DOI: | 10.3390/ph12020070 |
196.
E. Herdoiza Padilla,
P. Crauwels,
T. Bergner,
N. Wiederspohn,
S. Förstner,
R. Rinas,
A. Ruf,
M. Kleemann,
R. Handrick,
J. Tuckermann,
K. Otte,
P. Walther and
C. U. Riedel,
"mir-124-5p Regulates Phagocytosis of Human Macrophages by Targeting the Actin Cytoskeleton via the ARP2/3 Complex.",
Frontiers in immunology,
vol. 10,
pp. 2210,
2019.
DOI: | 10.3389/fimmu.2019.02210 |
195.
A. Wagner,
B. Alan,
D. Yilmaz,
M. Ahmad,
P. Liu,
N. K. Tangudu,
J. P. Tuckermann and
M. Vujic Spasic,
"Despite Genetic Iron Overload, , javax.xml.bind.JAXBElement@e709a68, -Hemochromatosis Mice Do Not Show Bone Loss.",
JBMR plus,
vol. 3,
pp. e10206,
Sep.
2019.
DOI: | 10.1002/jbm4.10206 |
194.
M. Motta,
M. Fidan,
E. Bellacchio,
F. Pantaleoni,
K. Schneider-Heieck,
S. Coppola,
G. Borck,
L. Salviati,
M. Zenker,
I. C. Cirstea and
M. Tartaglia,
"Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.",
Human molecular genetics,
vol. 28,
pp. 1007--1022,
Mä.
2019.
DOI: | 10.1093/hmg/ddy412 |
193.
S. Beevi,
N. Tangudu,
V. Verma and
L. Dinesh Kumar,
"Biodrug Suppresses Breast and Colorectal Cancer in Murine Models",
Methods Mol Biol.,
vol. 1974,
pp. 245-263,
2019.
192.
L. T. C. M. Weert,
J. C. Buurstede,
H. C. M. Sips,
S. Vettorazzi,
I. M. Mol,
J. Hartmann,
S. Prekovic,
W. Zwart,
M. V. Schmidt,
B. Roozendaal,
J. P. Tuckermann,
R. A. Sarabdjitsingh and
O. C. Meijer,
"Identification of mineralocorticoid receptor target genes in the mouse hippocampus.",
Journal of neuroendocrinology,
vol. 31,
pp. e12735,
Aug.
2019.
DOI: | 10.1111/jne.12735 |
191.
M. Wepler,
J. M. Preuss,
T. Merz,
C. Hartmann,
U. Wachter,
O. McCook,
J. Vogt,
S. Kress,
M. Gröger,
M. Fink,
A. Scheuerle,
P. Möller,
E. Calzia,
U. Burret,
P. Radermacher,
J. P. Tuckermann and
S. Vettorazzi,
"Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.",
Frontiers in immunology,
vol. 10,
pp. 3152,
2019.
DOI: | 10.3389/fimmu.2019.03152 |
2018
190.
A. Kalvisa,
M. Siersbæk,
S. Præstholm,
L. Christensen,
R. Nielsen,
O. Stohr,
S. Vettorazzi,
J. Tuckermann,
M. White,
S. Mandrup and
L. Grøntved,
"Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver",
PLoS Biol.,
vol. 16,
no. 12,
pp. e2006249,
Dez.
2018.
189.
M. Motta,
M. Fidan,
E. Bellacchio,
F. Pantaleoni,
K. Schneider-Heieck,
S. Coppola,
G. Borck,
L. Salviati,
M. Zenker,
I. Cirstea and
M. Tartaglia,
"Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the kelch domain substrate-recognition surface and enhance RAS-MAPK signaling",
Hum Mol Genet.,
vol. 28,
no. 6,
pp. 1007-1022,
Nov.
2018.
188.
M. Aramacki,
A. Trugenberger,
A. Ellwanger,
T. Eiseler,
C. Schwerdt,
L. Bettac,
D. Langgartner,
N. Azoitei,
R. Halbgebauer,
R. Groß,
T. Barth,
A. Lechel,
B. Walter,
J. Kraus,
C. Wiegreffe,
J. Grimm,
A. Scheffold,
M. Schneider,
K. Peuker,
S. Zeißig,
S. Britsch,
S. Rose-John,
S. Vettorazzi,
E. Wolf,
A. Tannapfel,
K. Steinestel,
S. Reber,
P. Walther,
H. Kestler,
P. Radermacher,
T. Barth,
M. Huber-Lang,
A. Kleger and
T. Seufferlein,
"Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure",
J Clin Invest.,
vol. 128,
no. 11,
pp. 5056-5072,
Nov.
2018.
187.
M. Koenen,
S. Culemann,
S. Vettorazzi,
G. Caratti,
L. Frappart,
W. Baum,
G. Krönke,
U. Baschant and
J. P. Tuckermann,
"Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis",
Ann Rheum Dis.,
vol. 77,
no. 11,
pp. 1610-1618,
Nov.
2018.
186.
C. Scholtysek,
N. Ipseiz,
C. Böhm,
B. Krishnacoumar,
M. Stenzel,
T. Czerwinski,
K. Palumbo-Zerr,
T. Rothe,
D. Weidner,
A. Klej,
C. Stoll,
J. Distler,
J. Tuckermann,
M. Herrmann,
B. Fabry,
W. Goldmann,
G. Schett and
G. Krönke,
"NR4A1 regulates motility of osteoclast precursors and serves as target for the modulation of systemic bone turnover",
J Bone Miner Res.,
vol. 33,
no. 11,
pp. 2035-2047,
Nov.
2018.
185.
M. Ahmad,
T. Kroll,
J. Jakob,
A. Rauch,
A. Ploubidou and
J. Tuckermann,
"Cell-based RNAi screening and high-content analysis in primary calvarian osteoblasts applied to identification of osteoblast differentiation regulators",
Sci Rep.,
vol. 8,
no. 1,
pp. 14045,
Sep.
2018.